
GLASGOW – Siemens Healthineers, which manufactures instruments, reagents and consumables across a range of laboratory diagnostic products, will invest $32 million into an expansion of its operations in Delaware.
The German company was approved Monday for roughly $2 million in taxpayer-backed grants to expand at its site off Route 896 rather than move the operations elsewhere. That included a retention grant worth up to $1.3 million for maintaining its workforce and a $690,000 capital expenditure grant to support the plant buildout.
Siemens plans to expand its largest building at its Glasgow-area campus by 29,000 square feet, adding more capacity to manufacture up to 20 new in vitro diagnostic assays as well as additional associated calibrator products. That construction is expected to take about two years.
The project aims to boost the company’s manufacturing capabilities at the facility to accommodate growth in its manufacturing operations for the Atellica Solution, a high-tech immunoassay and clinical chemistry analyzer. Siemens reported that it wanted to tighten up its diagnostic supply chain while reducing the need to outsource parts of its manufacturing process by investing in this expansion.

This won’t be the last time that Siemens likely scales up in Delaware. It has future plans for adding another more than 60,000 square feet after this latest announced expansion, according to plans filed with New Castle County. That would increase the size of the current 234,000-square-foot building by about 40%.
The company currently has more than 1,300 full-time employees at the campus – ranking it the 23rd largest employer in the county by Delaware Business Times records – including approximately 500 employees in manufacturing and technical positions such as operators, technicians, chemists and engineers. It owns approximately 135 acres and leases multiple facilities in the Glasgow Business Community park, which sits across from Pencader Corporate Center and dates back originally to DuPont. Siemens arrived in Glasgow in 2007 after it acquired Dade Behring, a laboratory diagnostics company that had operated there for more than a decade after acquiring DuPont’s diagnostic unit.
Deepak Nath, president of laboratory diagnostics at Siemens, said that part of the expansion would include relocation of “important test manufacturing to this facility, which will streamline some of our processes and further improve the efficiency with which we can deliver these important tests to health care providers and their patients.”
The expansion of a major medical technology manufacturer was heralded by Gov. John Carney as evidence of Delaware’s competitive business climate, touting the presence of manufacturing as the state pushes for more such jobs.
“Delaware is a great place for innovative manufacturing companies like Siemens Healthineers to grow their operations,” Carney said in a statement. “We are pleased Siemens Healthineers will be making a significant investment in our state to enhance and expand their manufacturing facility, which will keep good-paying jobs here in Delaware.”